501 related articles for article (PubMed ID: 33906783)
1. Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection.
Chan CK; Chang YY; Tsai YC; Chen ZW; Wu CY; Huang WC; Yen IW; Wu KH; Wu VC; Lin YH;
J Formos Med Assoc; 2021 Oct; 120(10):1811-1820. PubMed ID: 33906783
[TBL] [Abstract][Full Text] [Related]
2. Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Huang KH; Yu CC; Hu YH; Chang CC; Chan CK; Liao SC; Tsai YC; Jeff Chueh SC; Wu VC; Lin YH;
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):72-82. PubMed ID: 29506889
[TBL] [Abstract][Full Text] [Related]
3. Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Wu VC; Hu YH; Er LK; Yen RF; Chang CH; Chang YL; Lu CC; Chang CC; Lin JH; Lin YH; Wang TD; Wang CY; Tu ST; Jeff Chueh SC; Chang CC; Tseng FY; Wu KD;
J Formos Med Assoc; 2017 Dec; 116(12):993-1005. PubMed ID: 28735660
[TBL] [Abstract][Full Text] [Related]
4. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
[TBL] [Abstract][Full Text] [Related]
5. Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis.
Chang CC; Chen YY; Lai TS; Zeng YH; Chen CK; Tu KH; Lu CC; Wu VC; Er LK;
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):121-129. PubMed ID: 32855034
[TBL] [Abstract][Full Text] [Related]
6. Primary Aldosteronism: Present and Future.
Funder JW
Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
[TBL] [Abstract][Full Text] [Related]
7. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
Riester A; Reincke M
Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
[TBL] [Abstract][Full Text] [Related]
8. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
9. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.
Funder JW; Carey RM; Fardella C; Gomez-Sanchez CE; Mantero F; Stowasser M; Young WF; Montori VM;
J Clin Endocrinol Metab; 2008 Sep; 93(9):3266-81. PubMed ID: 18552288
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
11. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
12. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
14. Primary aldosteronism in pregnancy.
Forestiero V; Sconfienza E; Mulatero P; Monticone S
Rev Endocr Metab Disord; 2023 Feb; 24(1):39-48. PubMed ID: 35536535
[TBL] [Abstract][Full Text] [Related]
15. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
16. [The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age].
Bohdanowicz-Pawlak A; Szymczak J; Jakubowska J; Brona A
Endokrynol Pol; 2009; 60(6):492-6. PubMed ID: 20041369
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Wang E; Chomsky-Higgins K; Chen Y; Nwaogu I; Seib CD; Shen WT; Duh QY; Suh I
J Surg Res; 2019 Apr; 236():37-43. PubMed ID: 30694777
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary hyperaldosteronism.
Araujo-Castro M
Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
[TBL] [Abstract][Full Text] [Related]
19. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
20. Personalized Treatment of Patients With Primary Aldosteronism.
Obeid H; Chen Cardenas SM; Khairi S; Turcu AF
Endocr Pract; 2023 Jun; 29(6):484-490. PubMed ID: 36273684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]